The macula densa prorenin receptor is essential in renin release and blood pressure control

Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F521-F534. doi: 10.1152/ajprenal.00029.2018. Epub 2018 Apr 18.

Abstract

The prorenin receptor (PRR) was originally proposed to be a member of the renin-angiotensin system (RAS); however, recent work questioned their association. The present paper describes a functional link between the PRR and RAS in the renal juxtaglomerular apparatus (JGA), a classic anatomical site of the RAS. PRR expression was found in the sensory cells of the JGA, the macula densa (MD), and immunohistochemistry-localized PRR to the MD basolateral cell membrane in mouse, rat, and human kidneys. MD cell PRR activation led to MAP kinase ERK1/2 signaling and stimulation of PGE2 release, the classic pathway of MD-mediated renin release. Exogenous renin or prorenin added to the in vitro microperfused JGA-induced acute renin release, which was inhibited by removing the MD or by the administration of a PRR decoy peptide. To test the function of MD PRR in vivo, we established a new mouse model with inducible conditional knockout (cKO) of the PRR in MD cells based on neural nitric oxide synthase-driven Cre-lox recombination. Deletion of the MD PRR significantly reduced blood pressure and plasma renin. Challenging the RAS by low-salt diet + captopril treatment caused further significant reductions in blood pressure, renal renin, cyclooxygenase-2, and microsomal PGE synthase expression in cKO vs. wild-type mice. These results suggest that the MD PRR is essential in a novel JGA short-loop feedback mechanism, which is integrated within the classic MD mechanism to control renin synthesis and release and to maintain blood pressure.

Keywords: fluorescent reporter mice; juxtaglomerular apparatus; macula densa; prorenin receptor; renin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Biosensing Techniques
  • Blood Pressure* / drug effects
  • Captopril / pharmacology
  • Cyclooxygenase 2 / metabolism
  • Diet, Sodium-Restricted
  • Dinoprostone / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • HEK293 Cells
  • Humans
  • Juxtaglomerular Apparatus / drug effects
  • Juxtaglomerular Apparatus / enzymology*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Prorenin Receptor
  • Prostaglandin-E Synthases / metabolism
  • Proton-Translocating ATPases / deficiency
  • Proton-Translocating ATPases / genetics
  • Proton-Translocating ATPases / metabolism*
  • Rats, Sprague-Dawley
  • Receptors, Cell Surface / deficiency
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*
  • Renin / metabolism*
  • Renin-Angiotensin System* / drug effects
  • Secretory Pathway
  • Signal Transduction
  • Vacuolar Proton-Translocating ATPases / genetics
  • Vacuolar Proton-Translocating ATPases / metabolism*

Substances

  • ATP6AP2 protein, human
  • ATP6AP2 protein, mouse
  • Angiotensin-Converting Enzyme Inhibitors
  • Receptors, Cell Surface
  • Captopril
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Extracellular Signal-Regulated MAP Kinases
  • Renin
  • Vacuolar Proton-Translocating ATPases
  • Proton-Translocating ATPases
  • Prostaglandin-E Synthases
  • Ptges protein, mouse
  • Dinoprostone
  • Prorenin Receptor